Quick Answer
Boundless Bio, Inc. reported Total Assets of $157.06 million for fiscal year 2025.
Boundless Bio, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $157.06M | -23.9% |
| 2024 | $206.41M | +58.9% |
| 2023 | $129.89M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $168.72M | -3.6% | -6.0% |
| June 30, 2025 | $179.45M | -4.6% | -6.2% |
| March 31, 2025 | $191.24M | +63.3% | -7.3% |
| December 31, 2024 | $206.41M | +58.9% | +17.9% |
| September 30, 2024 | $175.09M | — | -7.0% |
| June 30, 2024 | $188.20M | — | +60.8% |
| March 31, 2024 | $117.08M | — | -9.9% |
| December 31, 2023 | $129.89M | — | — |
- Boundless Bio, Inc. showed a decrease of -23.9% in Total Assets compared to the prior fiscal year.
- Over the 2023–2025 period, Boundless Bio, Inc.’s total assets has grown by 20.9% (from $129.89 million to $157.06 million).
- The most recent figure is from Boundless Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: